This invention relates to compositions and methods for selective expression of a heterologous nucleic acid sequence in a targeted tissue, and more particularly to the glucose regulated protein 78 (grp78) stress-responsive promoter and its use in gene therapy and the production of transgenic animals.

 
Web www.patentalert.com

< Method of vaccination comprising linear and circular expression elements

< Type F botulinum toxin and use thereof

> Topical anti-microbial compositions

> Method for the chromatographic fractionation of plasma or serum, preparations, so obtained, and their use

~ 00263